COVID-19 Vaccines Safe for Patients Treated for Lung Cancer with Immune Checkpoint Inhibitors
Photo: Pixabay/CC0 Public Domain
Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors. Now, a new study published in the Journal of Thoracic Oncology found that vaccines are safe and effective for these patients.
Patients with cancer are at an increased risk for SARS-CoV-2 infection and severe COVID-19 because of the lowered immunity associated with anticancer drugs, radiation therapy, and cancer itself, as well as increased exposure due to frequent visits to the ...